Vivos (RDGL) Income from Continuing Operations (2010 - 2025)
Vivos (RDGL) posted Income from Continuing Operations of 1078514.0 for Q4 2025, down 112.6% sequentially from 507294.0 in Q3 2025, and down 5.41% YoY from 1140165.21 in Q4 2024.
Vivos (RDGL) Income from Continuing Operations (2010 - 2025) Analysis & Trends
Vivos has reported Income from Continuing Operations for 16 years, with the latest figure at 1078514.0 in Q4 2025.
- Quarterly Income from Continuing Operations fell 5.41% year-over-year to 1078514.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 3066017.0 (down 5.35% YoY) and the FY2025 annual result came in at 3066017.0, down 5.35% from the prior year.
- Income from Continuing Operations declined to 1078514.0 in Q4 2025 per RDGL's latest filing, from 507294.0 in the prior quarter.
- Over five years, Income from Continuing Operations peaked at 178230.0 in Q4 2021 and troughed at 1860187.0 in Q2 2021.
- A 5-year average of 693457.25 and a median of 683797.5 in 2022 frame the typical range for Income from Continuing Operations.
- The sharpest annual moves came in 2021 and 2023: Income from Continuing Operations tumbled 1069.29% in 2021, then soared 64.52% in 2023.
- Over 5 years, Income from Continuing Operations stood at 178230.0 in 2021, then tumbled by 295.92% to 705653.0 in 2022, then sank by 52.51% to 1076219.0 in 2023, then rose by 4.93% to 1023188.0 in 2024, then slipped by 5.41% to 1078514.0 in 2025.
- According to Business Quant data, Income from Continuing Operations over the past three periods registered 1078514.0, 507294.0, and 645513.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 1.28 Bn |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 1.26 Bn |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 905.00 Mn |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 241.40 Mn |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 249.10 Mn |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 574.00 Mn |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 1.04 Bn |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Vivos | 24.90 Mn | 23.34 Mn | -3,105.00 | -1.08 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.08 Mn |
| Sep 30, 2025 | -507,294.00 |
| Jun 30, 2025 | -645,513.00 |
| Mar 31, 2025 | -834,696.00 |
| Dec 31, 2024 | -1.02 Mn |
| Sep 30, 2024 | -825,263.00 |
| Jun 30, 2024 | -503,458.00 |
| Mar 31, 2024 | -558,539.00 |
| Dec 31, 2023 | -1.08 Mn |
| Sep 30, 2023 | -667,690.00 |
| Jun 30, 2023 | -902,526.00 |
| Mar 31, 2023 | -248,318.00 |
| Dec 31, 2022 | -705,653.00 |
| Sep 30, 2022 | -277,065.00 |
| Jun 30, 2022 | -787,538.00 |
| Mar 31, 2022 | -699,905.00 |
| Dec 31, 2021 | -178,230.00 |
| Sep 30, 2021 | -201,160.00 |
| Jun 30, 2021 | -1.86 Mn |
| Mar 31, 2021 | -288,189.00 |